In this article, written with Joshua D. Wright, Joanna Tsai documents and analyzes changes to 11 SSO IPR policies over time and show that SSOs and their IPR policies appear to be responsive to changes in perceived patent holdup risks and other factors. To read more, click the link below.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...